Miura Global Management Has Cut Its Accelerate Diagnostics (AXDX) Holding by $17.16 Million; Market Value Declined; Mar Vista Investment Partners Has Lowered Facebook (FB) Holding by $629,200

May 18, 2018 - By Dolores Ford

Facebook, Inc. (NASDAQ:FB) Logo

Pasco Alfaro / Richard Tumure decreased its stake in Accelerate Diagnostics Inc (AXDX) by 68.75% based on its latest 2017Q4 regulatory filing with the SEC. Miura Global Management Llc sold 660,000 shares as the company’s stock declined 17.34% with the market. The hedge fund run by Pasco Alfaro / Richard Tumure held 300,000 shares of the capital goods company at the end of 2017Q4, valued at $7.86M, down from 960,000 at the end of the previous reported quarter. Miura Global Management Llc who had been investing in Accelerate Diagnostics Inc for a number of months, seems to be less bullish one the $1.20B market cap company. The stock increased 2.31% or $0.5 during the last trading session, reaching $22.15. About 362,468 shares traded or 55.53% up from the average. Accelerate Diagnostics, Inc. (NASDAQ:AXDX) has declined 0.88% since May 18, 2017 and is downtrending. It has underperformed by 12.43% the S&P500.

Mar Vista Investment Partners Llc decreased its stake in Facebook Inc (FB) by 0.99% based on its latest 2017Q4 regulatory filing with the SEC. Mar Vista Investment Partners Llc sold 3,575 shares as the company’s stock declined 14.10% with the market. The institutional investor held 356,755 shares of the technology company at the end of 2017Q4, valued at $62.95M, down from 360,330 at the end of the previous reported quarter. Mar Vista Investment Partners Llc who had been investing in Facebook Inc for a number of months, seems to be less bullish one the $531.92B market cap company. The stock increased 0.31% or $0.56 during the last trading session, reaching $183.76. About 13.86M shares traded. Facebook, Inc. (NASDAQ:FB) has risen 8.48% since May 18, 2017 and is uptrending. It has underperformed by 3.07% the S&P500.

Since February 20, 2018, it had 7 buys, and 0 sales for $4.73 million activity.

Analysts await Accelerate Diagnostics, Inc. (NASDAQ:AXDX) to report earnings on August, 2. They expect $-0.37 earnings per share, down 19.35% or $0.06 from last year’s $-0.31 per share. After $-0.37 actual earnings per share reported by Accelerate Diagnostics, Inc. for the previous quarter, Wall Street now forecasts 0.00% EPS growth.

Miura Global Management Llc, which manages about $2.90B and $344.33M US Long portfolio, upped its stake in Asml Holding N V (NASDAQ:ASML) by 20,000 shares to 120,000 shares, valued at $20.86M in 2017Q4, according to the filing.

More recent Accelerate Diagnostics, Inc. (NASDAQ:AXDX) news were published by: Nasdaq.com which released: “Accelerate Diagnostics announces sizeable release of new data at ECCMID 2018” on April 21, 2018. Also Globenewswire.com published the news titled: “Accelerate Diagnostics to Review First Quarter 2018 Results on May 9th” on April 30, 2018. Nasdaq.com‘s news article titled: “Report: Developing Opportunities within US Ecology, Universal Health Realty Income Trust, Accelerate Diagnostics …” with publication date: May 04, 2018 was also an interesting one.

Among 4 analysts covering Accelerate Diagnostics (NASDAQ:AXDX), 3 have Buy rating, 0 Sell and 1 Hold. Therefore 75% are positive. Accelerate Diagnostics had 9 analyst reports since August 25, 2015 according to SRatingsIntel. The rating was downgraded by BTIG Research on Wednesday, December 13 to “Neutral”. The stock of Accelerate Diagnostics, Inc. (NASDAQ:AXDX) has “Overweight” rating given on Tuesday, August 9 by JP Morgan. JP Morgan initiated Accelerate Diagnostics, Inc. (NASDAQ:AXDX) rating on Thursday, March 24. JP Morgan has “Overweight” rating and $17 target. The firm has “Buy” rating by Piper Jaffray given on Thursday, August 3. The rating was upgraded by BTIG Research to “Neutral” on Tuesday, August 25. As per Wednesday, July 12, the company rating was reinitiated by BTIG Research. The firm has “Overweight” rating given on Wednesday, December 16 by Piper Jaffray. The firm earned “Buy” rating on Sunday, September 17 by Piper Jaffray. William Blair initiated Accelerate Diagnostics, Inc. (NASDAQ:AXDX) on Friday, January 8 with “Outperform” rating.

Investors sentiment decreased to 0.81 in 2017 Q4. Its down 0.82, from 1.63 in 2017Q3. It dived, as 21 investors sold AXDX shares while 32 reduced holdings. 15 funds opened positions while 28 raised stakes. 19.90 million shares or 6.66% less from 21.32 million shares in 2017Q3 were reported. Tci Wealth Advsrs holds 0.01% or 500 shares in its portfolio. Next Century Growth Invsts Lc accumulated 660,020 shares. Reilly Advisors Ltd invested in 1,000 shares. Pnc Fincl Service Gru Inc reported 3,200 shares. Oz Mngmt Limited Partnership owns 53,100 shares. J Goldman & Communication LP holds 0.01% of its portfolio in Accelerate Diagnostics, Inc. (NASDAQ:AXDX) for 3,783 shares. California State Teachers Retirement holds 41,156 shares or 0% of its portfolio. State Bank Of America De owns 20,477 shares. D E Shaw And Inc invested in 31,426 shares or 0% of the stock. Great West Life Assurance Can owns 2,080 shares. Citigroup holds 0% or 2,693 shares. 9,000 were accumulated by Barbara Oil. Loomis Sayles And LP reported 0.03% stake. Chartist Inc Ca holds 0.75% or 64,765 shares in its portfolio. Parametric Associate Limited Liability Com stated it has 30,470 shares.

Since December 7, 2017, it had 0 insider buys, and 54 insider sales for $2.31 billion activity. The insider Sandberg Sheryl sold 55,000 shares worth $10.28 million. $4.82 million worth of Facebook, Inc. (NASDAQ:FB) was sold by Schroepfer Michael Todd on Thursday, February 15. The insider Koum Jan sold $231.84 million. The insider Stretch Colin sold $134,821. On Tuesday, February 27 FISCHER DAVID B. sold $3.29M worth of Facebook, Inc. (NASDAQ:FB) or 17,830 shares. The insider Cox Christopher K sold $2.83 million.

Mar Vista Investment Partners Llc, which manages about $1.80B and $2.67B US Long portfolio, upped its stake in Pepsico Inc (NYSE:PEP) by 3,136 shares to 392,239 shares, valued at $47.04M in 2017Q4, according to the filing. It also increased its holding in Schlumberger Ltd (NYSE:SLB) by 5,026 shares in the quarter, for a total of 1.08M shares, and has risen its stake in Johnson & Johnson (NYSE:JNJ).

More notable recent Facebook, Inc. (NASDAQ:FB) news were published by: Livetradingnews.com which released: “Facebook, Inc. (NASDAQ:FB) A Look Inside the Technicals” on May 17, 2018, also Seekingalpha.com with their article: “Facebook – Case Settled” published on May 13, 2018, Seekingalpha.com published: “Facebook’s Watch” on May 15, 2018. More interesting news about Facebook, Inc. (NASDAQ:FB) were released by: Nasdaq.com and their article: “Thursday’s Vital Data: Facebook, Inc. (FB), Apple Inc. (AAPL) and Alibaba Group Holding Ltd (BABA)” published on May 17, 2018 as well as Nasdaq.com‘s news article titled: “Tencent’s Advertising Business Is Just Getting Started” with publication date: May 17, 2018.

Analysts await Facebook, Inc. (NASDAQ:FB) to report earnings on July, 25. They expect $1.72 earnings per share, up 30.30% or $0.40 from last year’s $1.32 per share. FB’s profit will be $4.98 billion for 26.71 P/E if the $1.72 EPS becomes a reality. After $1.69 actual earnings per share reported by Facebook, Inc. for the previous quarter, Wall Street now forecasts 1.78% EPS growth.

Investors sentiment increased to 1.21 in Q4 2017. Its up 0.06, from 1.15 in 2017Q3. It is positive, as 57 investors sold FB shares while 621 reduced holdings. 147 funds opened positions while 670 raised stakes. 1.61 billion shares or 1.26% less from 1.63 billion shares in 2017Q3 were reported. First Fincl Bank Of Hutchinson accumulated 0.81% or 7,702 shares. Redwood Invs Lc has invested 1.54% in Facebook, Inc. (NASDAQ:FB). Triangle Secs Wealth Mgmt has 1,300 shares for 0.13% of their portfolio. 10 were accumulated by Hillsdale Inv Management. Firsthand Management holds 5.85% or 45,000 shares in its portfolio. 123,581 were accumulated by Friess Assoc Ltd Com. Quantres Asset Mgmt Ltd holds 0.9% or 8,100 shares in its portfolio. Levin Cap Strategies LP owns 7,051 shares for 0.02% of their portfolio. Overbrook Mgmt has invested 3.27% of its portfolio in Facebook, Inc. (NASDAQ:FB). Maplelane Capital invested in 1.3% or 335,000 shares. 4,335 are owned by Wall Street Access Asset Mngmt Limited Liability. Zwj Investment Counsel invested 0.18% of its portfolio in Facebook, Inc. (NASDAQ:FB). Peak6 Invests LP holds 0.27% or 328,475 shares in its portfolio. Daiwa Sb Invests Ltd holds 0.58% or 12,430 shares in its portfolio. Reliant Invest Management Limited Liability Corporation reported 19,610 shares.

Facebook, Inc. (NASDAQ:FB) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts